Bone Biologics Completes $5.75 Million Funding Round

Bone Biologics completed a US $5.75MM funding round with participation from Musculoskeletal Transplant Foundation, Orthofix and Hankey Capital. Proceeds will support development and synthesis of a potential bone graft substitute, with an initial focus on spinal fusion applications.

Source: Bone Biologics

Bone Biologics developed Nell-1™...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us